1287402009: Filgotinib (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Transferase inhibitor\Phosphotransferase inhibitor\Protein kinase inhibitor\Protein-tyrosine kinase inhibitor\Janus kinase inhibitor\Filgotinib

\Substance categorised by structure\Chemical\Chemical categorized by structure\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Pyridine and/or pyridine derivative\Pyridine\Filgotinib

\Organic compound\Organic cyclic compound\Heterocyclic compound (substance)\Pyridine and/or pyridine derivative\Pyridine\Filgotinib
\Organic compound\Organic nitrogen compound\Pyridine and/or pyridine derivative\Pyridine\Filgotinib

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2023. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

5258015019 Filgotinib en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

5258016018 Filgotinib (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

5258015019 Filgotinib en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

5258016018 Filgotinib (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Filgotinib	Is a	Pyridine	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Filgotinib	Is a	Janus kinase inhibitor	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Filgotinib	Has disposition	Janus kinase inhibitor (disposition)	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Filgotinib maleate	Is modification of (attribute)	True	Filgotinib	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely filgotinib (as filgotinib maleate) 100 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Filgotinib	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Filgotinib (as filgotinib maleate) 200 mg oral tablet	Has basis of strength substance (attribute)	True	Filgotinib	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing filgotinib (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Filgotinib	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only filgotinib (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Filgotinib	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing filgotinib in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Filgotinib	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only filgotinib in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Filgotinib	Inferred relationship	Existential restriction modifier (core metadata concept)	1

This concept is not in any reference sets